reference/24367117

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24367117

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	E8387
issn	0027-8424 1091-6490
issueIdentifier	36
pageRange	E8378-E8387
publicationName	Proceedings of the National Academy of Sciences of the United States of America
startingPage	E8378
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e3c18600b59b2612497bf6b95256a2d6 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ca0b45962a5a62ef43f07123284f7022
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c8d18da2f33c079156e7833860f9e062 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f54247d8ac1a2fb3b7f10d083fbe1992 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_601f5159c00f251aa0fcc2c304460d88
bibliographicCitation	Juraska M, Magaret CA, Shao J, Carpp LN, Fiore-Gartland AJ, Benkeser D, Girerd-Chambaz Y, Langevin E, Frago C, Guy B, Jackson N, Duong Thi Hue K, Simmons CP, Edlefsen PT, Gilbert PB. Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials. Proc Natl Acad Sci U S A. 2018 Sep 04;115(36):E8378–87. PMID: 30127007; PMCID: PMC6130398.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_598262a6f0c0352008933e7fc77ac413 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15e5fceae8bfdcc2315bbc9b23742054 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_254666fe655b1a0f6571bba54693a1bc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4aead4c725fc2d86be583aa7c276a94d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2738fcf7503e92f2db61b7ea621871d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79f44ee65c67f163da42e903f5b1b6bd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7cb40d4f570359ad63ab2ae4907b3158 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5fa106ef2a4526a4f188457cd9878cbc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d9f96d184f5539b9a8510cd3fe1b273 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73508b4a0707df2e33597c71139948f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93be200d68f1bc4785f9ecf31373bee1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5488196f683264de07297f709535af77 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eecdae1658322ba18a1b7349bf7e724c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4d131c44bb6a1afb05ec546524ec11f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_607575fb36064778d99f95c9579f90b6
date	2018-08-20^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/30127007 https://pubmed.ncbi.nlm.nih.gov/PMC6130398 https://doi.org/10.1073/pnas.1714250115
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6653 https://portal.issn.org/resource/ISSN/0027-8424 https://portal.issn.org/resource/ISSN/1091-6490
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials
discusses	http://id.nlm.nih.gov/mesh/M0491092
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D005838 http://id.nlm.nih.gov/mesh/D053059Q000008 http://id.nlm.nih.gov/mesh/D014644 http://id.nlm.nih.gov/mesh/D003716Q000235 http://id.nlm.nih.gov/mesh/D003715Q000517
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D002675 http://id.nlm.nih.gov/mesh/D053059Q000235 http://id.nlm.nih.gov/mesh/D003716Q000276 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000367 http://id.nlm.nih.gov/mesh/D003715Q000276 http://id.nlm.nih.gov/mesh/D002648 http://id.nlm.nih.gov/mesh/D053059Q000276 http://id.nlm.nih.gov/mesh/D003715Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_efdbbf9d9f20cdf89f19d5cc9171b33b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7406

Showing number of triples: 1 to 60 of 60.